COMMUNIQUÉS West-GlobeNewswire

Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details
18/04/2024
BRENTWOOD, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will [...]
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
18/04/2024
Top-line data from ADX71149 Phase 2 epilepsy study expected by mid-May 2024 Launched Neurosterix with Perceptive Advisors, raising USD 63 million in Series A to accelerate development of preclinical portfolio Received [...]
BioSenic S.A. : Transparency notifications received from François Rieger
18/04/2024
PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, April 18, 2024, 7am CET – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical [...]
BioSenic S.A. : Notifications de transparence reçues de la part de François Rieger
18/04/2024
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes Mont-Saint-Guibert, Belgique, le 18 avril 2024 à 7h00 CET – BIOSENIC (Euronext [...]
BVI Launches PODEYE Hydrophobic Monofocal IOL in Japan
18/04/2024
Second BVI Market Debut in Less Than Twelve Months BVI continues to execute its roadmap of IOL launches in Japan, the world's third-largest IOL-valued market 1 The PODEYE hydrophobic monofocal is perfectly suited to the [...]
Intra-Cellular Therapies Prices Public Offering of Common Stock
18/04/2024
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for [...]
Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures
18/04/2024
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAD), a company focused on opportunities within and outside of the cannabis [...]
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
17/04/2024
Conference call and webcast scheduled for Thursday, April 25, 2024, at 8:00 am EDT / 2:00 pm. CEST PARIS and CAMBRIDGE, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ [...]
NANOBIOTIX publiera ses résultats financiers et opérationnels de l'exercice 2023 le 24 avril 2024
17/04/2024
Conférence téléphonique et diffusion en direct sur Internet le jeudi 25 avril 2024 à 14 h 00 CEST / 8 h 00 EDT PARIS et CAMBRIDGE, Mass., 17 avr. 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – [...]
Inari Medical to Announce First Quarter 2024 Financial Results
17/04/2024
IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
17/04/2024
SAN FRANCISCO, April 17, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of [...]
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
17/04/2024
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report [...]
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
17/04/2024
- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (NYSE American: SER), a [...]
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
17/04/2024
SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
17/04/2024
DENVER, April 17, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary solutions to reduce the [...]
ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN
17/04/2024
Les centres ASPIRE-FTD dans l’UE et aux États-Unis utiliseront la navigation ClearPoint® avec la canule SmartFlow® pour l’administration de thérapie génique intrathalamique SOLANA BEACH, Californie, 17 avr. 2024 (GLOBE [...]
Hospice Choices: VITAS® Healthcare Opens in Alabama, Expands in Florida Panhandle
17/04/2024
A Media Snippet accompanying this announcement is available by clicking on this link . TALLAHASSEE, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Hospice patients and their families in the Florida Panhandle and areas in [...]
River Oaks Treatment Center is Setting the Standard for Clinical Excellence in Florida with Four Board-Certified Addiction Medicine Physicians
17/04/2024
RIVERVIEW, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- River Oaks Treatment Center is proud to announce that it has two additional board-certified addiction medicine physicians on its staff. Dr. Michael Murphy and Dr. [...]
Ipsen publishes its 2023 Universal Registration Document
17/04/2024
Ipsen publishes its 2023 Universal Registration Document PARIS, FRANCE, 17 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty biopharmaceutical group, announces that its 2023 Universal Registration [...]

Pages